Casdin Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $897K | Hold |
723,767
| – | – | 0.08% | 27 |
|
|
2025
Q1 | $854K | Sell |
723,767
-312,092
| -30% | -$368K | 0.07% | 39 |
|
|
2024
Q4 | $1.9M | Hold |
1,035,859
| – | – | 0.13% | 33 |
|
|
2024
Q3 | $1.76M | Hold |
1,035,859
| – | – | 0.12% | 30 |
|
|
2024
Q2 | $1.42M | Hold |
1,035,859
| – | – | 0.11% | 32 |
|
|
2024
Q1 | $3.88M | Hold |
1,035,859
| – | – | 0.29% | 28 |
|
|
2023
Q4 | $10.2M | Hold |
1,035,859
| – | – | 1% | 23 |
|
|
2023
Q3 | $8.65M | Buy |
+1,035,859
| New | +$8.65M | 0.96% | 22 |
|
|
2022
Q2 | – | Sell |
-7,990,652
| Closed | -$72.7M | – | 46 |
|
|
2022
Q1 | $72.7M | Hold |
7,990,652
| – | – | 3.26% | 11 |
|
|
2021
Q4 | $163M | Hold |
7,990,652
| – | – | 4.61% | 7 |
|
|
2021
Q3 | $204M | Buy |
7,990,652
+2,990,652
| +60% | +$76.4M | 5.08% | 4 |
|
|
2021
Q2 | $175M | Hold |
5,000,000
| – | – | 4.44% | 6 |
|
|
2021
Q1 | $167M | Hold |
5,000,000
| – | – | 4.96% | 5 |
|
|
2020
Q4 | $130M | Buy |
5,000,000
+500,000
| +11% | +$13M | 3.84% | 8 |
|
|
2020
Q3 | $44.4M | Buy |
+4,500,000
| New | +$44.4M | 1.99% | 18 |
|
|
2017
Q3 | – | Sell |
-300,000
| Closed | -$1.07M | – | 30 |
|
|
2017
Q2 | $1.07M | Sell |
300,000
-400,000
| -57% | -$1.42M | 0.4% | 30 |
|
|
2017
Q1 | $3.62M | Buy |
+700,000
| New | +$3.62M | 2.14% | 15 |
|